Join a powerful, unprecedented alliance for better eye health for all.Join IAPB
For everyone’s health and safety, ophthalmologists, optometrists, and other doctors are being urged to see only patients for urgent or emergent problems during the coronavirus pandemic.
This is important for two reasons:
Urgent care is defined as medical care provided for illnesses or injuries that require prompt attention but are typically not of such seriousness as to require the services of an emergency room. Emergency care is defined as medical care for conditions requiring prompt medical attention due to a sudden change in the eye or visual health. If you’re uncertain whether or not your condition is urgent or emergent, contact your eye care provider (ophthalmologist or optometrist) immediately.
You will likely find that routine patient visits, such as annual dilated eye exams, exams for glasses, and general eye health check-ups, will be rescheduled likely for a few months. Any non-emergent or urgent eye surgeries and procedures, for example cataract surgery, will also be postponed. Whereas exams and surgeries for eye injuries, retinal detachments, and other eye problems resulting in acute vision loss that may be permanent if not treated sooner are still occurring. Contact your eye care provider’s office BEFORE going traveling to the office to check whether your appointment is cancelled or not.
Plan ahead: If your appointment will still occur, talk to the eye care provider’s office by phone about any safety precautions you should take for the visit. In addition, please let the office know if you have a cough or a fever, or have been in close contact with someone who has these symptoms. Offices have implemented screening and cleaning procedures to preserve the health and safety of the office staff and patients who needed to be seen.
Call your eye care provider for guidance in the following situations:
Clinical trials: If you are currently involved in a clinical trial for a vision treatment or therapy, the FDA has encouraged all trials to consider patients’ safety when making determinations about trial recruitment and continued participation and drug administration. Changes to the conduct of each trial and the participation of its patients will depend on the various circumstances of the trial, including the nature of the disease being studied and the drug being administered, potential changes in the product’s supply chain, the regions where the trial is conducted, and more.
Contact your clinical trial site to determine what steps they are taking to ensure your safety and continuity of eye care during this time. This may include changes to how the clinical trial maintains contact with you or how treatments are administered.
For more information on Corona Virus Eye Safety, visit the resources available through the American Academy of Ophthalmology and/or the American Optometric Association.